Gynecologic Cancer
Clinical Review
2023 Update on cervical disease
The World Health Organization’s “90-70-90” global strategy targets for vaccination, screening, and treatment to reduce the incidence of cervical...
Feature
What is the future for multicancer early-detection tests?
Liquid biopsies based on genomic biomarkers could make MCED a reality, especially for cancers for which there is no standard screening process.
Commentary
Two landmark papers change treatment paradigm for advanced endometrial cancer
The outcomes we have now are remarkably positive for patients and have absolutely changed the standard of care in the management of recurrent or...
From the Journals
Surgery approach may improve survival in advanced ovarian cancer
Latest News
Black women weigh emerging risks of ‘creamy crack’ hair straighteners
Mounting evidence now shows that chemical straighteners could be a health hazard.
Conference Coverage
Offering HPV vaccine at age 9 linked to greater series completion
Despite recommendations to bundle HPV vaccine administration with that of Tdap and meningococcal vaccines, offering it sooner increases the...
From the Journals
Routine thromboprophylaxis for advanced ovarian cancer?
“Two-thirds [of VTEs] may have been preventable” because they occurred between epithelial ovarian cancer diagnosis and interval cytoreductive...
From the Journals
Number of cervical cancer screenings linked to higher preterm birth risk
The optimal screening strategy must trade off the oncologic benefits of cancer detection against the neonatal harms of overtreatment.
Commentary
The surprising occupations with higher-than-expected ovarian cancer rates
This is how these types of studies work; they tend to raise more questions than they answer.
From the Journals
Catch-up HPV screenings help detect cancer in women over 65
Women older than 65 years account for about 20% of new cervical cancer cases.
Latest News
HPV rates skyrocket despite safe, effective vaccine
Low public awareness of the dangers of HPV may be behind young people’s poor vaccination rates.